Dabigatran Intermediate C |
|
Synonyms: N-[[2-[[(4-Cyanophenyl)amino]methyl]-1-methyl-1H-benzimidazol-5-yl]carbonyl]-N-2-pyridinyl-ß-alanine | |
Cat. No.: D00162 | CAS No.: 212322-77-5 |
MDL.: | Formula: C25H22N6O3 |
F.W.454.48 | Purity: 99% |
Storage: No Data Available | |
  |
Catalog Number: | D00162 | CAS No.: | 212322-77-5 | |
MDL: | Formula: | C25H22N6O3 | ||
F.W.: | 454.48 | Purity: | 99% | |
Package: | Unit: | mg | ||
Appearance: | No Data Available | M.P.: | No Data Available | |
B.P.: | Density: | |||
Optical Rotation: | Refractive Index: | |||
Solubility: | DCM, Methanol | Stability: | ||
Storage: | No Data Available | Category: | Reference Standard | |
Application: | N-[[2-[[(4-Cyanophenyl)amino]methyl]-1-methyl-1H-benzimidazol-5-yl]carbonyl]-N-2-pyridinyl-ß-alanine is an intermediate in the synthesis of Dabigatran, an nonpeptide, direct thrombin inhibitor. | |||
Category: | Aromatics, Heterocycles, Nucleotides, Bases & Related Reagents, Pharmaceuticals, Intermediates & Fine Chemicals |